Academic Hepatologist; Associate Chief of Medicine and Chief of GI/Hepatology @Miami VA; Associate Prof @UMiami, Interest in HCC, PBC, cirrhosis
Miami, FL
- Tweets 698
- Following 351
- Followers 409
- Likes 2,125
Pinned Tweet
Breaking news:@JAMAInternalMed #COVIDVaccination
->delayed in #cirrhosis but works against severe disease!
☝️One dose -> 64.8% ↓ #COVID19
✌️Two doses ->78.6%↓ COVID19 #livertwitter #medtwitter #GITwitter @MiamiVAMC @VCUHealth @VCU @UMiamiMedNews jamanetwork.com/journals/jam…
6
20
94
Binu John retweeted
Cheers to another successful AGA Leadership Summit! 👏🏼👏🏼👏🏼 Thank you, AGA leaders, for your ideas and leadership to grow the specialty! @VictorChedidMD @CulpepperJoan @JHashashMD @AndyChanMD @Jarshah4 @SultanShazi @drkylestaller @docbinujohn @priyanka_kanth
8
30
2,413
Binu John retweeted
Best practices for managing ascites, volume overload & hyponatremia in cirrhosis.
Our new CPU in @AGA_Gastro shares 1️⃣3️⃣ evidence-based tips to support clinical decision-making.
Read more here: ow.ly/4zLY50XLcfX
@orman_md @BrettEFortuneMD @AsraniSumeet
#GITwitter
4
73
179
16,388
Binu John retweeted
🔥Metylated blood-based HCC biomarker is more sensitive than US for #HCC surveillance. #TLM25
by @docbinujohn
@AASLDtweets @DrHuangDQ @Apichatka @wonglaihung
1
4
19
1,307
Binu John retweeted
🚨 New insights on managing hepatitis delta virus (HDV):
Our new CPU, published in @AGA_Gastro, highlights screening, diagnosis, and therapies.
📖 Read more: ow.ly/wOuS50X6oYO
@TatyanaKushner @Robert_J_Wong
#GItwitter
4
12
1,692
Binu John retweeted
Today was a full day with our #AGAleaders! Plenty of conversation to chart a path forward for AGA and the future of GI. 🙌🏼 @docbinujohn @LarryKimMD @DrLorenGR @MccutchenDr @MichelleKimMD @ShaziaMSiddique @JHashashMD @IBDimmunology
6
14
2,759
RT @docbinujohn: MASLD-HCC can occur in absence of cirrhosis
Our study 30,414 patients with MASLD in Hepatology
HCC risk ↑ by 18% per 5kPa…
9
MASLD-HCC can occur in absence of cirrhosis
Our study 30,414 patients with MASLD in Hepatology
HCC risk ↑ by 18% per 5kPa ↑ in LSM
In pts with MASLD without cirrhosis, LSM of ≥10 kPa and diabetes, HCC risk is high enough to warrant screening
lnkd.in/e5fHZHZ8
1
9
25
2,027
Binu John retweeted
We need to spread the word about MASH
Awareness is low, particularly amongst people at risk and frontline providers
Hot of the presses in @HepCommJournal journals.lww.com/hepcomm/ful… #easl2025
6
23
79
6,788
Grateful for the invitation to speak @cddw_clm on "Remote evaluation of liver transplantation" in beautiful Quebec with some great speakers from @UofT . @CynthiaTsien @NaziaSelzner
9
133
Binu John retweeted
Just found out the study section scheduled to review my grant today was canceled. I spent three months writing it, representing five years of work from my lab. Gutted. @NIH
84
370
2,112
169,118
Binu John retweeted
NEW in @LancetGastroHep: led by our @juanpabloarab, "Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective" 🍺 🍷 🍹 Needs integrated multidisciplinary teams. #livertwitter #alcoholism @JasmohanBajaj @saulkarpen
authors.elsevier.com/a/1kc07…
2
6
393
Binu John retweeted
🚨 NIH funding changes threaten #GIResearch labs and the future of GI patient care! 🚨 AGA President @ibddocmaria calls for action. Share your story about how these changes impact your work. Let's protect the future of digestive disease treatment! ow.ly/OZiz50UZL3Y
12
24
5,779
Binu John retweeted
DOGE @elonmusk approach feels like a surgeon trying to remove a small tumor using a saw instead of a scalpel, without pre-op imaging or taking a patient history, and also removing organs that aren’t diseased but that they just don’t like. And with med students doing the procedure
197
452
2,276
113,535
Binu John retweeted
📢 Live from #TLM2024
HCC debrief by Neehar Parikh
➡️ Liver stiffness may help refine HCC screening in MASLD pts
➡️ Are lower AFP levels better than the usual cutoffs for screening cured HCV, ALD, and MASLD patients?
@AASLDtweets
1
5
25
1,717
Good morning! If you are at #TLM2024 please join us @ 8 am in Ball room 6A where we present our data using liver stiffness measurement to predict HCC risk and to identify patients with MASLD who may qualify for surveillance! @docamitgs @AnjanaPillaiMD @nicole_rich8 @AASLDtweets
2
1
10
400
Good morning San Diego! It's nice to wake up to this view! Looking forward to an exciting day of learning, collaborating and catching up with friends, colleagues and mentors from all over the world! #TLM24 @AASLDtweets @AASLDFoundation @AASLDPresident #livertwitter
1
10
707
Binu John retweeted
Excited to return to my #IBD roots @IBDCedarsSinai to work alongside a great team. Come visit! @AmerGastroAssn
26
10
207
10,908
Binu John retweeted
New Clinical Practice Update in @AGA_Gastro from Drs. @AmitPatelDukeMD @Duke_GI_, @LorenLaine2, @PaulMoayyedi and Justin Wu offers 9️⃣ pieces of expert advice to guide the integration of P-CABs in the management of foregut disorders.
🔗 Learn more ow.ly/aPpy50U1tE3
17
46
6,757
Huge news 4 MASH (NASH). Semaglutide meets both primary end points for phase 3 trial- resolution of MASH & dec fibrosis!
Pleasant surprise as phase 2 study met only one! We should soon have a 2nd drug 4 MASH 🙌#livertwitter @AASLDtweets @AmerGastroAssn
ml-eu.globenewswire.com/Reso…
3
134
Binu John retweeted
2 days of intense research brainstorming for grants and studies to improve the care of patients with liver disease #VOCAL #PennYaleMiami
@mezzacappa_c @RabieeAnahita @serperm @KaplanDeLiver #TamarTaddei @docbinujohn @ggarciatsao
3
27
1,698